Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
Baxter India has launched the "Choose Freedom" education campaign to raise awareness of the critical importance of timely dialysis treatment and empower End Stage Kidney Disease (ESKD) patients with an understanding of Peritoneal Dialysis (PD) therapy that helps achieve the quadruple aim of better clinical outcomes, allowing patients to maintain their lifestyle and independence, and improving health care professionals' experiences.
Chronic Kidney Disease (CKD) is a growing epidemic and a rising global public health concern, with 850 million people affected worldwide. As a progressive disease, very often linked to diabetes, CKD can lead to kidney failure, also known as End Stage Kidney Disease (ESKD), which requires dialysis. Urgent action must be taken to address this growing health crisis and ensure those affected by the disease are empowered with the right resources to make informed decisions about treatment options.
The Choose Freedom campaign provides patients with the knowledge and confidence to have meaningful conversations about Peritoneal Dialysis and emphasises the potential positive impact of Shared Decision Making, a collaborative approach in which patients and their families work with healthcare professionals to choose the dialysis option that works best for their clinical condition, social circumstances, and lifestyle.
Dr. Tarun Jeloka, Senior Consultant, Manipal Hospital Banner, Pune, said, "CKD is an emerging global public health problem that can lead to End Stage Kidney Disease (ESKD) or kidney failure, which can be fatal if not treated timely. I recommend patients have prior discussions with their nephrologist regarding available dialysis options and make an informed decision about their therapy. Peritoneal Dialysis (PD) is a home-based dialysis option with a lower risk of infection that can be managed by the patient after appropriate training. It also allows patients to maintain their lifestyle and independence and provides the potential for improved clinical outcomes.”
Rishubh Gupta, General Manager, Baxter India Private Ltd., said, “World Kidney Day is an opportunity to draw attention to chronic kidney disease as well as its management through Peritoneal Dialysis. Baxter is committed to expanding access to PD therapy and enhancing the quality of care for ESKD patients. Our goal is to make PD the initial dialysis therapy of choice by providing smarter patient-centric solutions that enable you to give your patients the best possible care for chronic kidney disease."
Subscribe To Our Newsletter & Stay Updated